Early Access — free while we kick the tires
EdgarHawk

Mary L. Smith

Director

Director

Latest: Director selling · July 2026

1 filing analyzed · 1 company · Latest 2026-07-13

Never miss a filing from Mary L. Smith

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
PTC THERAPEUTICS, INC. PTCT 0 1 Net selling

Activity

July 2026
2026-07-13 PTC THERAPEUTICS, INC. PTCT 10b5-1 Plan
medium
Sell
15,834 shares
$1,425,060
Significance 5/10

Director Mary L. Smith sold 15,834 shares at $90.00 ($1.4M) under pre-arranged 10b5-1 plan at PTCT

Director Mary L. Smith executed 2 separate sales totaling 15,834 shares (15.8K shares) for $1,425,060.00 ($1.4M) at $90.00 on 2026-07-09 under a pre-arranged 10b5-1 trading plan adopted 2025-11-11, reducing her holdings from 37,647 shares to 21,813 shares. The sale occurred near the 52-week high of $90.87, with the stock currently trading at $81.33 (-10.5% from that high). This is a scheduled, non-discretionary transaction under the 10b5-1 framework, so no inference about conviction or market timing should be drawn from the execution date itself. The company posted net losses of $-2.8M in the latest quarter, though annual revenue growth reached +114.5%, creating mixed fundamental signals that the filing alone cannot resolve.

Related insiders